Evidence for adenosine/dopamine receptor interactions: indications for heteromerization.
about
The G protein-coupled receptor heterodimer network (GPCR-HetNet) and its hub componentsHeteromerization of G protein-coupled receptors: relevance to neurological disorders and neurotherapeutics.Formation of mu-/kappa-opioid receptor heterodimer is sex-dependent and mediates female-specific opioid analgesiaLow affinity binding of the classical D1 antagonist SCH23390 in rodent brain: potential interaction with A2A and D2-like receptorsFunctional characterization of G-protein-coupled receptors: a bioinformatics approach.Effects of adenosine receptor antagonists in MPTP mouse model of Parkinson's disease: mitochondrial DNA integrity.Gene-Environment Interaction in Parkinson's Disease: Coffee, ADORA2A, and CYP1A2.Role of antibodies in developing drugs that target G-protein-coupled receptor dimers.Adenosine A1 receptor gene variants associated with post-traumatic seizures after severe TBI.Pharmacology of signaling induced by dopamine D(1)-like receptor activationPurinergic signaling: a fundamental mechanism in neutrophil activation.Gene expression in peripheral arterial chemoreceptors.Computational methods in drug design: modeling G protein-coupled receptor monomers, dimers, and oligomersRoles of G-protein-coupled receptor dimerization.Adenosine A2A receptor in the monkey basal ganglia: ultrastructural localization and colocalization with the metabotropic glutamate receptor 5 in the striatum.Dimerization of the thyrotropin-releasing hormone receptor potentiates hormone-dependent receptor phosphorylation.Behavioural and biochemical responses to morphine associated with its motivational properties are altered in adenosine A(2A) receptor knockout miceThe origins of diversity and specificity in g protein-coupled receptor signalingHeteromeric dopamine receptor signaling complexes: emerging neurobiology and disease relevanceAllosteric modulators of g protein-coupled receptors: future therapeutics for complex physiological disorders.The role of dopaminergic signalling during larval zebrafish brain development: a tool for investigating the developmental basis of neuropsychiatric disorders.G-protein-coupled receptor type A heteromers as an emerging therapeutic target.Role of iso-receptors in receptor-receptor interactions with a focus on dopamine iso-receptor complexes.A Role for Adenosine A1 Receptors in GABA and NMDA-Receptor Mediated Modulation of Dopamine Release: Studies Using Fast Cyclic VoltammetryHIV-1 TAT protein enhances sensitization to methamphetamine by affecting dopaminergic function.Oligomerization of the fifth transmembrane domain from the adenosine A2A receptor.A(2A) adenosine receptor binding parameters in platelets from patients affected by pathological gambling.Receptor regulatory properties evident in the molecular similarity of dopamine receptor ligands and purine nucleotides.Moderate alcohol exposure during early brain development increases stimulus-response habits in adulthood.Ethanol operant self-administration in rats is regulated by adenosine A2 receptors.Adenosine A2A receptors are involved in physical dependence and place conditioning induced by THC.Vaccine-driven pharmacodynamic dissection and mitigation of fenethylline psychoactivity.Inhibition of perforant path input to the CA1 region by serotonin and noradrenaline.The lack of A2A adenosine receptors diminishes the reinforcing efficacy of cocaine.Gliotransmission and adenosinergic modulation: insights from mammalian spinal motor networks.Thalamic synaptic transmission of sensory information modulated by synergistic interaction of adenosine and serotonin.ADORA1 mutations are not a common cause of Parkinson's disease and dementia with Lewy bodies.Effect of the adenosine A2a receptor antagonist 3,7-dimethyl-propargylxanthine on anxiety-like and depression-like behavior and alcohol consumption in Wistar Rats.Potentiation of amphetamine-mediated responses in caffeine-sensitized rats involves modifications in A2A receptors and zif-268 mRNAs in striatal neurons.
P2860
Q24564171-089E5F43-1FCA-498E-B327-77629CFA4574Q24630645-6D1828BC-B96A-4093-915D-C0127AB58C25Q28568886-0773A9B5-C901-4DF7-A6DC-EEA0E1767DC5Q28585319-AE44B1CF-3DD7-4FD3-A5AC-5A263D8F2D3AQ30009384-B870EA2E-9707-4A19-919F-0CE9B99DEEBBQ33645993-C26E9799-06AB-4B08-ABC0-F66814C7B853Q33782664-5A897D69-F627-4DD6-A7B9-ACEEFE702EA5Q34051430-D93CA8FF-AC67-46FA-B524-199676F23685Q34104911-8C63C75E-2609-4F83-9811-010E63324498Q34126949-FD9360F2-4754-48EA-B8B5-07279F1810E7Q34406055-7B65E8F3-E2D5-445B-B990-5E956CB70F27Q34972598-06345A97-05F3-4C3D-B78B-918A6C7F3B35Q35594835-4B081F81-F1F2-4FAC-97CC-E760B8F43255Q35622424-7C4B1025-B690-41E0-B021-F17816A81E3BQ35917127-71DF5B0B-3C99-48D8-A586-65B0CCC909FDQ36156984-B24BAFA2-2216-408F-B1F6-E3AF67E5E346Q36977478-E58076AC-C362-496F-8CA1-604E4EBE23C6Q37131419-7382AB3E-322E-42DB-944A-6FD3EC6FA1DCQ37379456-4270ED0B-5A7D-4C36-8DAB-D70A9233404FQ37416470-674147DD-0C26-46D3-AD30-7D6491699A70Q37880098-255387D5-CFB6-445E-B4A5-FFF951157B18Q38266283-70046D1D-C4BE-47FE-9573-AA2B7DF76A45Q38595178-0943CB66-9CA1-45A5-BABB-D62E6AC8A579Q39164786-5BB92983-5235-4DFF-8A05-FD570B24AF26Q40204890-8579EC0B-6F7F-431E-B55E-02D166472B53Q43093904-82431D5F-59A6-4477-87BA-A219E6ABFF30Q43987980-8462F51A-A59A-49F5-9CB4-2965C9C8F353Q43989506-A3D5AC63-BA11-46E3-BBAE-0F6493C7CBEDQ44014209-00124A88-2DA2-4575-AFBF-3F3503670835Q45057379-0A1A4007-4903-451A-8D93-ECAAA5642E85Q45079498-22FFF269-6538-4960-A18F-6364AE2EF65FQ46157187-A33B8D6B-F2F5-461A-A696-DC91DC795DB4Q46486060-5ED04BD9-F180-43A5-9B33-D6DDE0AFA727Q46670474-F288B634-8E20-4A2F-9A0F-6AEA435D3D32Q48094337-4AC1B8BF-ECBE-48B1-B861-BD895776E91EQ48147752-5AC9EAC4-D75B-4A49-BD9B-D53A6D3F90C4Q48392446-50747953-2CB3-4E36-A026-FB23B6C67CE9Q48398090-A44E9CB4-3E74-41AC-A474-BDBA61969F73Q48498126-F2C1B6D7-0945-488D-84C7-AD6371285242
P2860
Evidence for adenosine/dopamine receptor interactions: indications for heteromerization.
description
2000 nî lūn-bûn
@nan
2000 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Evidence for adenosine/dopamine receptor interactions: indications for heteromerization.
@ast
Evidence for adenosine/dopamine receptor interactions: indications for heteromerization.
@en
Evidence for adenosine/dopamine receptor interactions: indications for heteromerization.
@nl
type
label
Evidence for adenosine/dopamine receptor interactions: indications for heteromerization.
@ast
Evidence for adenosine/dopamine receptor interactions: indications for heteromerization.
@en
Evidence for adenosine/dopamine receptor interactions: indications for heteromerization.
@nl
prefLabel
Evidence for adenosine/dopamine receptor interactions: indications for heteromerization.
@ast
Evidence for adenosine/dopamine receptor interactions: indications for heteromerization.
@en
Evidence for adenosine/dopamine receptor interactions: indications for heteromerization.
@nl
P2093
P1476
Evidence for adenosine/dopamine receptor interactions: indications for heteromerization.
@en
P2093
M Torvinen
P356
10.1016/S0893-133X(00)00144-5
P407
P433
P50
P577
2000-10-01T00:00:00Z
P5875
P6179
1027265773